Thalia Therapeutics Plc (AIM:THAT)
London · Delayed Price · Currency is GBP · Price in GBX 0.6700
+0.0200 (3.08%)
May 26, 2026, 4:11 PM GMT
Thalia Therapeutics Market Cap
Thalia Therapeutics has a market cap or net worth of 5.41 million as of May 26, 2026. Its market cap has increased by 36.84% in one year.
Market Cap
5.41M
Enterprise Value
3.68M
Revenue
7.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since May 3, 2017, Thalia Therapeutics's market cap has increased from 4.57M to 5.41M, an increase of 18.33%. That is a compound annual growth rate of 1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 5.41M | 23.81% |
| Dec 31, 2025 | 4.37M | 110.82% |
| Dec 31, 2024 | 2.07M | -9.28% |
| Dec 29, 2023 | 2.28M | -47.18% |
| Dec 30, 2022 | 4.32M | -46.33% |
| Dec 31, 2021 | 8.06M | -46.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 15.94M |
| Cizzle Biotechnology Holdings | 12.32M |
| Genflow Biosciences | 11.75M |
| Oxford BioDynamics | 8.15M |
| CRISM Therapeutics | 5.95M |
| OptiBiotix Health | 5.94M |
| Theracryf | 4.94M |
| Nuformix | 4.44M |